Undergraduate
Jim Antonopoulos has been named one of six new members of the board of directors of Telik, an oncology drug development company in San Diego. The new members will help manage Telik’s recent merger with MabVax Therapeutics. A principal in Canaccord Genuity’s investment banking group, Jim works primarily in the life sciences sector.